Sahar M. Hassany

Naturally Occurring Anti-coagulant Proteins in Patients with Liver Cirrhosis: Is it Valuable Markers for Disease Severity?

Sara M. Eltelawy, Soha S. Abdelmoem, Hanan Galal, Safa Khaled, Ahmed A. Alaghory & Sahar M. Hassany · Asian Journal of Research and Reports in Hepatology · 2021

Background: Hemostatic systems in cirrhotic patients are delicately balanced between pro- and anticoagulant factors and can be easily tipped to a hypo- or hypercoagulable status, resulting from decreased levels of procoagulant and anticoagulant factors synthesized by hepatocytes...

Open access Research Article

Coronavirus Disease 19 (COVID-19) in a Patient with Chronic HCV While on Direct-Acting Antiviral Therapy with a Worse Prognosis

Nahed A. Makhlouf, Hoda A. Makhlouf, Aliae A. R. Mohamed- Hussein, Ehab F. Moustafa, Amal A. Mahmoud & Sahar M. Hassany · Asian Journal of Research and Reports in Gastroenterology · 2020

Introduction:  The world is suffering a major global health pandemic caused by a new strain of the coronavirus (COVID-19). Herein, we encountered one case with COVID-19 and chronic HCV while on Direct Acting Antiviral Therapy. Case Presentation: A 58-year male patient had chronic...

Open access Research Article